Fast and accurate solution for high-resolution HLA typing using Oxford Nanopore sequencing technology, from sample to result in under 5 hours.

Detailed Description

Nanotype® is a comprehensive solution from Werfen for high-resolution HLA typing based on nanopore sequencing technology (Oxford Nanopore Technologies). Designed to deliver fast, accurate, and complete results, it provides detailed genomic information for 11 HLA loci in a single workflow, from sample to final analysis, in under 5 hours.

Nanotype Workflow

The Nanotype® workflow relies on a long-range PCR strategy covering all relevant HLA genes, followed by optimized library preparation and real-time sequencing. Thanks to the continuous, full-molecule read provided by nanopore technology, the system delivers results with fully assembled haplotypes, eliminating the need for subsequent ambiguous resolution phases.

Data analysis is performed using dedicated software, which provides allele assignment, automatic read validation, and intuitive visualization of the covered regions. Furthermore, it incorporates a clinical variant interpretation tool, facilitating decision-making in histocompatibility and transplant environments.

Nanotype® allows the sequencing of multiple samples in a single workflow, making it ideal for laboratories looking to optimize turnaround time without compromising quality or genetic coverage.

Key Features

High-resolution HLA typing based on Oxford Nanopore technology.
Comprehensive analysis of 11 HLA loci in a single workflow.
Fully assembled haplotypes without ambiguities.
Results in under 5 hours from sample to report.
Clear visualization of covered regions and detected variants.
Compatible with ONT sequencing devices (e.g., GridION).
Integrated data analysis with clinical interpretation.
Scalable for multiple samples.
Nanotype analysis software

Ordering Information

Kit name: Nanotype® Contents: reagents for amplification, library preparation, and bioinformatics analysis Loci coverage: HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, -DPB1 Technology: nanopore sequencing (Oxford Nanopore Technologies) Recommended platform: GridION Total process time: <5 hours (from DNA to result) Software: dedicated module with clinical variant interpretation

Area:

High resolution HLA typing, Immunology, Pre transplantation

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Devyser LynchFAP

Devyser LynchFAP is a targeted NGS solution for the analysis of germline variants associated with hereditary colorectal cancer syndromes. The assay enables the detection of SNVs, indels, and CNVs in genes related to Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP), also incorporating a specific LR-PCR for the correct localization of variants in…
Devyser
Next Generation Sequencing (NGS)

Devyser HBOC NGS

Devyser HBOC NGS is a fast and robust NGS solution aimed at the detection of germline variants in 12 genes associated with an increased risk of hereditary breast and ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53. It offers comprehensive and uniform coverage of all coding exons and exon/intron…
Devyser
Next Generation Sequencing (NGS)

Devyser BRCA NGS

Devyser BRCA NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1 and BRCA2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and copy number…
Devyser
Next Generation Sequencing (NGS)

Devyser BRCA PALB2 NGS

Devyser BRCA PALB2 NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1, BRCA2, and PALB2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and…
Devyser
Next Generation Sequencing (NGS)